Emcure Pharmaceuticals signs a distribution deal with Roche to supply CellCept, Mircera, and Neorecormon for nephrology and transplant care in India, effective April 1, 2026.
The Nifty slipped below 24,700 to its lowest level in a month, with losses broad-based across largecaps and midcaps. The early fall wiped out over…
PL Capital’s Research Analyst Jinesh Joshi said the Middle East crisis is pressuring aviation, with about 12% of IndiGo’s capacity impacted as a large share…
Indian markets fell as US Iran tensions rose, but experts advise staying calm, maintaining SIPs, diversifying, and focusing on fundamentals for long term stability.
Force Motors reported an 8.06% year-on-year rise in February sales at 3,890 units, driven by strong domestic demand, even as export volumes declined during the…
Mahindra & Mahindra’s decision to exit its agri-machinery business in Japan reflects a broader strategy to streamline operations and focus on stronger, profitable markets, according…
State-run NMDC reported a 16% year-on-year rise in both iron ore production and sales for February, even as its shares trade flat in the afternoon…
Ranjit Cirumalla, Senior Vice President-Research Agri, Chemicals at IIFL, said the Strait of Hormuz is critical for India’s fertiliser supply, as a large share of…
For the first two months of the year, the Nifty India Defence Index has gained 5% so far, with stocks like MTAR Technologies already having…
Indiacharts and Strike Money founder Rohit Srivastava said gold may not sustain sharp gains despite geopolitical uncertainty, as it typically rallies briefly before correcting. He…